FDA Inspection
Delaware Institute for Reproductive Medicine, P.ADelaware Institute for Reproductive Medicine, P.A – FDA Inspection, Jun 20, 2019
Record Details
This FDA Inspection record concerns Delaware Institute for Reproductive Medicine, P.A, with an inspection on June 20, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 20, 2019
- Product Type
- Biologics
View Company Profile
ID · 637058bc-c8e1-4b70-9344-456c2eccbe8a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1094217
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delaware Institute for Reproductive Medicine, P.A
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 26, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 8, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 13, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 16, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Delaware Institute for Reproductive Medicine, P.A
- FDA Inspection 1293390 - 2025-09-16
- FDA Inspection 1187482 - 2022-10-26
- FDA Inspection 1018967 - 2017-06-08
- FDA Inspection 925928 - 2015-05-13
- FDA Inspection 831892 - 2013-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.